Cyproheptadine, an antihistaminic drug, inhibits proliferation of hepatocellular carcinoma cells by blocking cell cycle progression through the activation of P38 MAP kinase

por Feng, Yu-Min, Feng, Chin-Wen, Chen, Syue-Yi, Hsieh, Hsiao-Yen, Chen, Yu-Hsin, Hsu, Cheng-Da
Publicado 2015

Stable Display of Artificially Long Foreign Antigens on Chimeric Bamboo mosaic virus Particles

por Chen, Tsung-Hsien, Hu, Chung-Chi, Lee, Chin-Wei, Feng, Yu-Min, Lin, Na-Sheng, Hsu, Yau-Heiu
Publicado 2021

Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patients

por Feng, Yu-Min, Feng, Chin-Wen, Lu, Chin-Li, Lee, Ming-Yang, Chen, Chi-Yi, Chen, Solomon Chih-Cheng
Publicado 2015

Efficacy of Cyproheptadine Monotherapy in Hepatocellular Carcinoma With Bone Metastasis: A Case Report

por Feng, Yu-Min, Chen, Tsung-Hsien, Berman, Dara, Chou, Chu-Kuang, Liao, Kai-Sheng, Hsieh, Ming-Chih, Chen, Chi-Yi
Publicado 2021

The Incidence of Bacteremia and Risk Factors of Post-Radiofrequency Ablation Fever for Patients with Hepato-Cellular Carcinoma

por Chen, Po-Yueh, Tsai, Tsung-Jung, Yang, Hsin-Yi, Chou, Chu-Kuang, Chang, Li-Jen, Chen, Tsung-Hsien, Hsu, Ming-Tse, Fang, Chien-Chung, Su, Chang-Chao, Lin, Yu-Ling, Feng, Yu-Min, Chen, Chi-Yi
Publicado 2021